Hsueh-Chou Lai

7PUBLICATIONS
20CO-AUTHORS
Veterinary virologyCancer therapy (excl. chemotherapy and radiation therapy)Cardiology (incl. cardiovascular diseases)Predictive and prognostic markersClinical midwifery
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 06, 2026
Darunavir and Fosamprenavir Inhibit Zika Virus Replication via Dual Targeting of the Envelope Protein and NS2B-NS3 Protease.

|Apr 20, 2026
Absence of steatosis combined with cardiometabolic risk factors confers the highest hepatocellular carcinoma risk in treated chronic hepatitis B.

|May 24, 2025
Impact of Hepatitis C Virus Clearance on Cardiovascular Risk: A Real-World Experience From the Nationwide Taiwan Hepatitis C Virus Registry.

Ping-Jen Hu, Pei-Chien Tsai, Chi-Yi Chen

|Nov 18, 2024
Real-world experience of lenvatinib-based therapy in patients with advanced hepatocellular carcinoma.

Hung-Wei Wang, Hsueh-Chou Lai, Wen-Pang Su

|Dec 24, 2021
Effective Antiviral Activity of the Tyrosine Kinase Inhibitor Sunitinib Malate against Zika Virus.

Chen-Sheng Lin, Su-Hua Huang, Bo-Yu Yan

|Aug 23, 2018
Letter: cohort study examining the association between proton pump inhibitor therapy and risk of hepatocellular carcinoma in Taiwan.

K-F Liao, H-C Lai, C-L Lin

Pageof 2

Frequent Collaborators

4 joint publications

Cheng-Yuan Peng

3 joint publications

Hung-Wei Wang

2 joint publications

Cheng-Wen Lin

2 joint publications

Wei-Fan Hsu